The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


PEBI  PORT ERIN BIOPHARMA INVESTMENTS LIMITED  ORD 0.0001P

PORT ERIN  Currency GBX 
Company



Price +/- Var % Volume Last close
7.12 0.00 +0.00% - 7.12 on 22-May-2013

Bid Offer Trading status
6.75 7.50 Periodic Auction Call
High Low Special conditions
7.75 7.12 NONE
As at 23-May-2013 10:44:05 -  All data delayed by at least 15 minutes.

Latest news
Select source   

Trading Information
23-May-2013
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register IM
Segment ASQ1
MiFID Status MTF
Exchange market size 7,000
SEDOL B6QH1J2
ISIN number IM00B6QH1J21

Last 5 trades
Time/Date Price Volume Trade value Type
16:29:48  22-May-13 6.75 28,000 1,890.00 O
09:57:38  22-May-13 7.25 100,000 7,250.00 O
09:26:10  22-May-13 7.25 37,500 2,718.75 O
16:05:56  20-May-13 6.90 25,000 1,725.00 O
15:37:03  20-May-13 6.55 15,000 982.50 O

Fundamentals
Content provided by Morningstar
Key Fundamentals 30-Jun-12
Revenue (£ m)   0.00
Pre-Tax (£ m)   0.43
EPS  1.81p
PE  3.45
PEG  n/a
EPS Growth  n/a
Dividend Cover  n/a
Dividend Yield  0.00%


Company Information
Updated Monthly
Company address 18 Athol Street, Douglas, IM1 1JA, United Kingdom
Company website -
Market cap(in millions)* £ 2.35
Listing/Admission to trading 15 Sep 2011
Trading service SETSqx
Market AIM
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

PORT ERIN price

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds